Tori Allen says she’s thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

Results from Novo Nordisk's STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight ...

The analyses – of a trial called Select, whose results ... three months, before reaching a plateau. A previous clinical trial ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

A high-dose form of Novo’s obesity drug led to 20% weight loss over 72 weeks. Meanwhile, Atara got a complete response letter ...

Following Wegovy's success, Eli Lilly introduced Zepbound after receiving US Food and Drug ... Recent head-to-head trial results demonstrated the superior efficacy of Zepbound over Wegovy, leading ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 ... Services Secretary Xavier Becerra told reporters. “It lets us go after the biggest cost drivers in the prescription drug field for ...

Results from a study of a higher dose of Wegovy disappointed investors and European drug regulators said they were investigating cases of a rare eye condition after concerns it could be linked to ...

WASHINGTON (AP) — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug ...

Results from a study of a higher dose of Wegovy disappointed investors and European drug regulators said they were investigating cases of a rare eye condition after concerns it could ... a parting ...